Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1992 1
1993 1
1995 1
1996 2
1998 1
2001 1
2003 1
2007 4
2008 3
2010 5
2011 6
2012 7
2013 4
2014 4
2015 5
2016 10
2017 8
2018 24
2019 27
2020 21
2021 39
2022 39
2023 41
2024 51
2025 75
2026 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

392 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity.
Heide J, Bilecz AJ, Patnaik S, Allega MF, Donle L, Yang K, Teich E, Li Y, Lin Q, Kong K, Liu L, Yang TG, Cheng KC, Shrimp JH, Hanson QM, Shen M, Sun H, Shah H, Schweizer L, Zawieracz K, Olland A, White A, Suto RK, Alhunayan R, Taşdemir M, Longman N, Liang H, Mann M, Stott GM, Hall MD, Schwörer S, Weichselbaum RR, Piffkó A, Lengyel E. Heide J, et al. Nature. 2025 Sep;645(8082):1051-1059. doi: 10.1038/s41586-025-09303-5. Epub 2025 Jul 23. Nature. 2025. PMID: 40702186 Free PMC article.
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309).
Yang Y, Pan J, Wang H, Zhao Y, Qu S, Chen N, Chen X, Sun Y, He X, Hu C, Lin L, Yu Q, Wang S, Wang G, Lei F, Wen J, Yang K, Lin Z, Guo Y, Chen S, Huang X, Wu Y, Liang L, Chen C, Bai F, Ma X, Zhang Y, Leaw S, Zhang L, Fang W. Yang Y, et al. Cancer Cell. 2023 Jun 12;41(6):1061-1072.e4. doi: 10.1016/j.ccell.2023.04.014. Epub 2023 May 18. Cancer Cell. 2023. PMID: 37207654 Free article. Clinical Trial.
Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion.
Zhang T, Li Y, Zhai E, Zhao R, Qian Y, Huang Z, Liu Y, Zhao Z, Xu X, Liu J, Li Z, Liang Z, Wei R, Ye L, Ma J, Wu Q, Chen J, Cai S. Zhang T, et al. Cancer Res. 2025 May 15;85(10):1819-1841. doi: 10.1158/0008-5472.CAN-24-2580. Cancer Res. 2025. PMID: 39992708 Free PMC article.
Single-cell RNA sequencing uncovered that F. nucleatum recruited tumor-associated neutrophils (TAN) to reshape the tumor immune microenvironment. Mechanistically, F. nucleatum invaded gastric cancer cells and activated IL17/NF-kappaB/RelB signaling, inducing TAN rec …
Single-cell RNA sequencing uncovered that F. nucleatum recruited tumor-associated neutrophils (TAN) to reshape the tumor immune micro …
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial.
Cortés J, Hurvitz SA, Im SA, Iwata H, Curigliano G, Kim SB, Chiu JWY, Pedrini JL, Li W, Yonemori K, Bianchini G, Loi S, Borges GS, Wang X, Bachelot T, Nakatani S, Ashfaque S, Liang Z, Egorov A, Hamilton E. Cortés J, et al. Nat Med. 2024 Aug;30(8):2208-2215. doi: 10.1038/s41591-024-03021-7. Epub 2024 Jun 2. Nat Med. 2024. PMID: 38825627 Free PMC article. Clinical Trial.
Glycan shielding enables TCR-sufficient allogeneic CAR-T therapy.
Wu Z, Shi J, Lamao Q, Qiu Y, Yang J, Liu Y, Liang F, Sun X, Tang W, Chen C, Yang Q, Wang C, Li Z, Zhang H, Yang Z, Zhang Y, Yi Y, Zheng X, Sun Y, Ma K, Yu L, Yang H, Wang Z, Zheng W, Yang L, Zhang Z, Zhang Y, Wu Z, Wang Y, Wong CCL, Jin M, Yuan P, Han W, Wei W. Wu Z, et al. Cell. 2025 Oct 30;188(22):6317-6334.e21. doi: 10.1016/j.cell.2025.07.046. Epub 2025 Aug 21. Cell. 2025. PMID: 40845838 Free article. Clinical Trial.
A visual-language foundation model for computational pathology.
Lu MY, Chen B, Williamson DFK, Chen RJ, Liang I, Ding T, Jaume G, Odintsov I, Le LP, Gerber G, Parwani AV, Zhang A, Mahmood F. Lu MY, et al. Nat Med. 2024 Mar;30(3):863-874. doi: 10.1038/s41591-024-02856-4. Epub 2024 Mar 19. Nat Med. 2024. PMID: 38504017 Free PMC article.
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models.
Ren F, Aliper A, Chen J, Zhao H, Rao S, Kuppe C, Ozerov IV, Zhang M, Witte K, Kruse C, Aladinskiy V, Ivanenkov Y, Polykovskiy D, Fu Y, Babin E, Qiao J, Liang X, Mou Z, Wang H, Pun FW, Torres-Ayuso P, Veviorskiy A, Song D, Liu S, Zhang B, Naumov V, Ding X, Kukharenko A, Izumchenko E, Zhavoronkov A. Ren F, et al. Nat Biotechnol. 2025 Jan;43(1):63-75. doi: 10.1038/s41587-024-02143-0. Epub 2024 Mar 8. Nat Biotechnol. 2025. PMID: 38459338 Free PMC article. Clinical Trial.
A multimodal generative AI copilot for human pathology.
Lu MY, Chen B, Williamson DFK, Chen RJ, Zhao M, Chow AK, Ikemura K, Kim A, Pouli D, Patel A, Soliman A, Chen C, Ding T, Wang JJ, Gerber G, Liang I, Le LP, Parwani AV, Weishaupt LL, Mahmood F. Lu MY, et al. Nature. 2024 Oct;634(8033):466-473. doi: 10.1038/s41586-024-07618-3. Epub 2024 Jun 12. Nature. 2024. PMID: 38866050 Free PMC article.
Literature Commentary.
[No authors listed] [No authors listed] J Neuroophthalmol. 2023 Mar 1;43(1):e26-e36. doi: 10.1097/WNO.0000000000001813. Epub 2023 Jan 18. J Neuroophthalmol. 2023. PMID: 40418693
JAMA Neurol. 2022;79:1105-1112.Cortese R, Carrasco FP, Tur C, Bianchi A, Brownlee W, De Angelis F, De La Paz I, Grussu F, Haider L, Jacob A, Kanber B, Magnollay L, Nicholas RS, Trip A, Yiannakas M, Toosy AT, Hacohen Y, Barkhof F, Ciccarelli O. ...Evalu …
JAMA Neurol. 2022;79:1105-1112.Cortese R, Carrasco FP, Tur C, Bianchi A, Brownlee W, De Angelis F, De La Paz I, Grussu F, Haid …
392 results